Glisolamide, a new sulfanylurea. Pharmacologic characteristics
D'Alò, G.; Dalla Vedova, R.; Cadel, S.; Campi, G.; Wassermann, A.
Bollettino Chimico Farmaceutico 117(6): 348-367
1978
ISSN/ISBN: 0006-6648 PMID: 743381 Document Number: 127681
Document emailed within 1 workday
Related Documents
Dalla Vedova, R.; Cadel, S.; D'Alò, G. 1979: Study of the protective activity of glisolamide on experimental atherosclerosis in the rabbit Giornale di Clinica Medica 60(11): 911-926Parvini, S.; Hamann, S.R.; Martin, W.R. 1993: Pharmacologic characteristics of a medullary hyperalgesic center Journal of Pharmacology and Experimental Therapeutics 265(1): 286-293
Bousquet, P.; Gayet, J-Louis. 2003: Pharmacologic characteristics of rosuvastatin, a new HMG-CoA reductase inhibitor Therapie 58(2): 113-121
Klygul', T.A.; Garibova, T.L.; Vikhliaev, I.I. 1975: Experimental characteristics of the spectrum of pharmacologic activity of the tranquilizer lorazepam Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 75(3): 435-438
Kovalenko, E.A.; Katkov, A.I.; Popkov, V.L.; Bobrovnitskiĭ, M.P.; Chabdarova, R.N. 1985: Comparative characteristics of the antihypoxic efficacy of pharmacologic preparations and barochamber training in man Fiziologiia Cheloveka 11(5): 808-813
Klouchek-Popova, E.; Popov, A.; Krusteva, S. 1984: Pharmacologic and cytomorphologic characteristics of a drug which stimulates the healing of traumatic and surgical wounds Khirurgiia 37(1): 17-20
Krulov, A.A.; Simonenko, M.G. 1987: Characteristics and pharmacologic prevention of cardiovascular system reactions in blood donors with borderline arterial hypertension Kardiologiia 27(8): 83-84
Costa, F.V. 1988: Clinical pharmacologic aspects of mepartricin. Possible pharmacologic interference with digitaloids and anticoagulants Minerva Urologica e Nefrologica 40(2 Suppl): 5-6
Sleptsova, S.I. 1987: Effects of various pharmacologic and non-pharmacologic agents on the mother and fetus (data for the health promotion propaganda) Akusherstvo i Ginekologiia 12: 68-71
Bannwarth, B. 2003: Antalgic, pharmacologic and non-pharmacologic treatments La Revue du Praticien 53(16): 1819-1826
Del Rosso, J.Q.; Kircik, L.H. 2013: The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream Journal of Drugs in Dermatology: Jdd 12(2): S5
Waalkes, T.P.; Makulu, D.R. 1976: Pharmacologic aspects of pentamidine National Cancer Institute Monograph 43: 171-177
De Montigny, P.; Clerc, C.; Descarpentries, C. 2006: Pharmacologic treatment of diabetes Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 4(2): 30-34
Honorato Pérez, J.; Azanza Perea, J.R.; Cuena Boy, R. 1984: Pharmacologic treatment of ulcers Revista de Medicina de la Universidad de Navarra 28(2): 53-58
Pinals, R.S. 1992: Pharmacologic treatment of osteoarthritis Clinical Therapeutics 14(3): 336-46; Discussion 335
Schipper, J. 1992: Fluvoxamine--pharmacologic properties Ceskoslovenska Psychiatrie 88(5): 225
1973: Pharmacologic effects of anisodamine Zhonghua yi xue za zhi 53(5): 269-273
Eisenberg, M.J.; Pilote, L. 1992: Pharmacologic stress echocardiography Annals of Internal Medicine 117(2): 168; Author Reply 168-9
Felder, M. 1998: Pharmacologic pain treatment Praxis 87(9): 295-299
Shaw, D.H.; Rubin, S.I. 1986: Pharmacologic activity of doxycycline Journal of the American Veterinary Medical Association 189(7): 808-810